Human erythropoietin is mostly produced by kidneys. It usually stimulates the human bone marrow to produce red blood cells. Inadequate production of human erythropoietin could lead to severe anemia. Epoetin alfa is an artificially made human erythropoietin. Developed by recombinant DNA technology, epoetin alfa acts as a catalyst to stimulate human erythropoietin production. Epoetin alfa is used to treat severe anemia, various neurological diseases, and cancer. It lowers the requirements of blood transfusion.
The global epoetin alfa therapeutics market is driven by high prevalence of anemia and neurological abnormalities, high diagnosis and treatment rate of cancer and anemia, favorable medical reimbursements, and strong health care infrastructure. High R&D investments and technological advancements are projected to propel the global epoetin alfa therapeutics market in the near future. However, side effects associated with epoetin alfa therapy such as joint pain, itching, headache, cough, rash, and nausea are anticipated to act as restraints of the global epoetin alfa therapy market during the forecast period.
Epoetin alfa therapy is mostly used to treat anemia and several types of cancer. According to a research published in the Current Treatment Options in Neurology, epoetin alfa has shown positive results in the treatment of traumatic brain injury, subarachnoid hemorrhage, and stroke. In terms of application, the global epoetin alfa therapeutics market can be segmented into anemia, cancer, neurology, and others. Based on route of administration, epoetin alfa therapeutics market can be classified into subcutaneous and intravenous. In terms of distribution channel, the global epoetin alfa therapeutics market has been divided into hospital pharmacies, retail pharmacies, drug stores and others.
Geographically, the global epoetin alfa therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. A ten-year study on prevalence of anemia in the U.S. revealed that 3% to 5% of the U.S. population suffered from anemia in 2016. Prevalence of anemia in Europe was estimated at 6% to 7% in 2016. Moreover, a significant population of these two regions suffer from cancer and neurological disorders. High prevalence of anemia, neurological disorders, and cancer, high treatment cost, availability of medical reimbursement, well-established medical infrastructure, and technological advancements drive the epoetin alfa therapeutics market in North America and Europe. Asia Pacific is expected to account for the third largest share of the epoetin alfa therapeutics market. However, epoetin alfa therapeutics market in the region is anticipated to expand at the highest growth rate during the forecast period. This is attributed to large population, market penetration of epoetin alfa products, and technological developments. Furthermore, highest percentage of population suffer from anemia in Africa; more than 10% of the population of the region suffered from anemia in 2016. High prevalence of anemia, low awareness, lack of treatment of anemia, and unavailability of epoetin alfa products in Africa are the major factors that restrain epoetin alfa therapeutics market in Middle East & Africa.
Key players in the global epoetin alfa therapeutics market include Amgen, Inc., and Janssen Products, LP (a Johnson and Johnson Company).
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.